Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allegretta M., Nicklas J. A., Sriram S., Albertini R. J. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science. 1990 Feb 9;247(4943):718–721. doi: 10.1126/science.1689076. [DOI] [PubMed] [Google Scholar]
- Bornstein M. B., Miller A., Slagle S., Weitzman M., Crystal H., Drexler E., Keilson M., Merriam A., Wassertheil-Smoller S., Spada V. A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med. 1987 Aug 13;317(7):408–414. doi: 10.1056/NEJM198708133170703. [DOI] [PubMed] [Google Scholar]
- Ebers G. C., Bulman D. E., Sadovnick A. D., Paty D. W., Warren S., Hader W., Murray T. J., Seland T. P., Duquette P., Grey T. A population-based study of multiple sclerosis in twins. N Engl J Med. 1986 Dec 25;315(26):1638–1642. doi: 10.1056/NEJM198612253152603. [DOI] [PubMed] [Google Scholar]
- Harcourt G. C., Sommer N., Rothbard J., Willcox H. N., Newsom-Davis J. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. J Clin Invest. 1988 Oct;82(4):1295–1300. doi: 10.1172/JCI113729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kissel J. T., Burrow K. L., Rammohan K. W., Mendell J. R. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group. Neurology. 1991 May;41(5):667–672. doi: 10.1212/wnl.41.5.667. [DOI] [PubMed] [Google Scholar]
- Mantegazza R., Hughes S. M., Mitchell D., Travis M., Blau H. M., Steinman L. Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma. Neurology. 1991 Jul;41(7):1128–1132. doi: 10.1212/wnl.41.7.1128. [DOI] [PubMed] [Google Scholar]
- Melms A., Schalke B. C., Kirchner T., Müller-Hermelink H. K., Albert E., Wekerle H. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest. 1988 Mar;81(3):902–908. doi: 10.1172/JCI113401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mulder D. G., Graves M., Herrmann C. Thymectomy for myasthenia gravis: recent observations and comparisons with past experience. Ann Thorac Surg. 1989 Oct;48(4):551–555. doi: 10.1016/s0003-4975(10)66861-0. [DOI] [PubMed] [Google Scholar]
- Olsson T., Baig S., Höjeberg B., Link H. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Ann Neurol. 1990 Feb;27(2):132–136. doi: 10.1002/ana.410270207. [DOI] [PubMed] [Google Scholar]
- Schwimmbeck P. L., Dyrberg T., Drachman D. B., Oldstone M. B. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest. 1989 Oct;84(4):1174–1180. doi: 10.1172/JCI114282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steinman L., Mantegazza R. Prospects for specific immunotherapy in myasthenia gravis. FASEB J. 1990 Jul;4(10):2726–2731. doi: 10.1096/fasebj.4.10.2197152. [DOI] [PubMed] [Google Scholar]
- Wraith D. C., McDevitt H. O., Steinman L., Acha-Orbea H. T cell recognition as the target for immune intervention in autoimmune disease. Cell. 1989 Jun 2;57(5):709–715. doi: 10.1016/0092-8674(89)90786-1. [DOI] [PubMed] [Google Scholar]
- Wucherpfennig K. W., Ota K., Endo N., Seidman J. G., Rosenzweig A., Weiner H. L., Hafler D. A. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science. 1990 May 25;248(4958):1016–1019. doi: 10.1126/science.1693015. [DOI] [PubMed] [Google Scholar]